Search

L‐Proline is a natural anti‐oxidative and osmoprotectant agent, playing a versatile role in cell metabolism and physiology. The present study aimed to explore the antioxidant effects of L‐Proline on human sperm function during incubation. Thirty healthy, normozoospermic men (27–40 years) were enrolled. Sperm samples were incubated in an unsupplemented sperm medium (control group), or supplemented with L‐Proline (1, 2 and 4 mmol/L) to evaluate its effect during 0, 1, 4 and 24 h of incubation. Sperm were assessed in terms of motility, viability, morphology, chromatin and DNA integrity. Moreover, the levels of reactive oxygen species (ROS), malondialdehyde (MDA), and total antioxidant capacity (TAC) were determined in the sperm medium. The results indicated that 2 mmol/L of L‐Proline significantly improved the maintenance of sperm motility, viability, normal morphology, chromatin and DNA integrity, and TAC levels compared to the control group during 24 h of incubation (p < 0.05). However, 1 and 4 mmol/L of L‐Proline could not significantly preserve sperm parameters, chromatin quality, and antioxidant status during different incubation times compared to the control group (p > 0.05). Collectively, the inclusion of L‐Proline (2 mmol/L) in the human sperm medium maintains sperm parameters and chromatin quality probably by modulating the oxidative status. [ABSTRACT FROM AUTHOR]

The inclusion of antioxidants (AOXs) has been proposed in various protocols to conserve the normal physiology of spermatozoa during (cryo) preservation. The main aim of this review was to understand the necessity of AOXs inclusion in semen extenders of caprine and ovine semen samples and to decipher physico‐chemical space of AOXs used in semen extenders till now. A total 27 full‐text relevant articles were finally discussed here. This systematic review showed that the inclusion of AOXs may improve the success of semen cryopreservation although at least three studies could not support this finding. AOXs have been not added after assaying total antioxidant capacity of the sample of interest, and this is principal measurement bias of all papers. Furthermore, no rational dose–response curve and precise posology have been considered in comparable studies. Furthermore, new methodologies are requested to detect the oxidative status of semen specimens before AXOs fortification and new methodologies like imaging are also needed to detect various injuries of sperms during semen (cryo)preservation. Defining computational chemical and physical spaces of AOXs which used in semen (cryo)preservation would be an interdisciplinary effort to hasten deciphering epoch‐making compounds. In conclusion, more in‐depth analytical, toxicological and pharmacological methodologies should be pursued in supplementation or addition of AOXs during caprine and ovine semen (cryo)preservation after determining the oxidative status of semen samples. [ABSTRACT FROM AUTHOR]

Citalopram is the most potent selective serotonin reuptake inhibitor, commonly prescribed as an antidepressant, which can cause sexual dysfunction. Melatonin is a natural, highly effective antioxidant playing a pivotal role in the male reproductive system. The present study aimed to explore the ameliorating potential of melatonin on citalopram-evoked testicular toxicity and injury in mice. In this regard, mice were randomly divided into six groups: control, citalopram, melatonin 10 mg/kg, melatonin 20 mg/kg, melatonin 10 mg/kg plus citalopram, and melatonin 20 mg/kg plus citalopram. Adult male mice were intraperitoneally (i.p.) injected with 10 mg/kg of citalopram for 35 days with or without melatonin. At the end of the study, sperm parameters, testosterone level, testicular levels of malondialdehyde (MDA), nitric oxide (NO), total antioxidant capacity (TAC), and apoptosis (Tunel essay) were evaluated. Our findings revealed that melatonin restored spermatogenesis by improving sperm count, motility, viability, morphology, and chromatin integrity. Testosterone levels and the histopathology of the testes were markedly improved in the melatonin-administrated groups. Furthermore, citalopram administration significantly increased oxidative stress; however, melatonin restored antioxidant status by enhancing TAC levels and decreasing NO and MAD levels. More notably, citalopram therapy induced a significant increase in the number of Tunel-positive cells, while melatonin administration significantly mitigated the apoptotic impacts of citalopram. Together, melatonin therapy provides protection against citalopram-induced testicular damage via modulating nitro-oxidative stress and apoptosis, which provides evidence for melatonin as a promising treatment against antidepressant drug-associated reproductive toxicity and male sub/infertility. • Melatonin attenuates citalopram-induced testicular toxicity and sperm damage. • Melatonin regulates nitro-oxidative stress and apoptosis in testes. • The beneficial effects of melatonin were not dose-dependent. • Melatonin could alleviate antidepressant-associated reproductive toxicity. [ABSTRACT FROM AUTHOR]